Inspiration Healthcare Group plc

DB:LXD1 Stock Report

Market Cap: €13.6m

Inspiration Healthcare Group Past Earnings Performance

Past criteria checks 0/6

Inspiration Healthcare Group's earnings have been declining at an average annual rate of -55.2%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 12.2% per year.

Key information

-55.2%

Earnings growth rate

-57.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate12.2%
Return on equity-34.9%
Net Margin-28.5%
Last Earnings Update31 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Inspiration Healthcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:LXD1 Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 2434-10180
30 Apr 2436-8180
31 Jan 2438-6180
31 Oct 2339-3180
31 Jul 2341-1180
30 Apr 23410170
31 Jan 23410160
31 Oct 22412160
31 Jul 22413160
30 Apr 22414160
31 Jan 22414160
31 Oct 21424160
31 Jul 21444160
30 Apr 21404150
31 Jan 21373140
31 Oct 20302120
31 Jul 20241100
30 Apr 2021180
31 Jan 2018170
31 Oct 1917160
31 Jul 1916160
30 Apr 1916160
31 Jan 1915160
31 Oct 1816150
31 Jul 1816140
30 Apr 1816140
31 Jan 1815140
31 Oct 1715140
31 Jul 1714040
30 Apr 1714040
31 Jan 1714040
31 Oct 1614140
31 Jul 1614150
30 Apr 1613050
31 Jan 1612050
31 Oct 1511050
31 Jul 1511040
30 Apr 1510040
31 Jan 1510130
31 Jan 149120

Quality Earnings: LXD1 is currently unprofitable.

Growing Profit Margin: LXD1 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LXD1 is unprofitable, and losses have increased over the past 5 years at a rate of 55.2% per year.

Accelerating Growth: Unable to compare LXD1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LXD1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: LXD1 has a negative Return on Equity (-34.91%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 01:54
End of Day Share Price 2025/01/10 00:00
Earnings2024/07/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inspiration Healthcare Group plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher DonnellanCavendish Historical (Cenkos Securities)
Seb JantetPanmure Liberum